Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Diet Rich in Tomatoes May Lower Breast Cancer Risk

By BiotechDaily International staff writers
Posted on 08 Jan 2014
Print article
A diet rich in tomatoes may help protect at-risk postmenopausal women from breast cancer, according to new research. Moreover, fruits were found to raise levels of hormone involved in regulating blood sugar and fat.

The new findings were published December 2013, online, ahead of print in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Breast cancer risk increases in postmenopausal women as their body mass index climbs. The study’s researchers discovered that eating a diet high in tomatoes had a beneficial effect on the level of hormones that play a role in regulating fat and sugar metabolism. “The advantages of eating plenty of tomatoes and tomato-based products, even for a short period, were clearly evident in our findings,” said the study’s first author, Adana Llanos, PhD, MPH, who is an assistant professor of epidemiology at Rutgers University (New Brunswick, NJ, USA). “Eating fruits and vegetables, which are rich in essential nutrients, vitamins, minerals, and phytochemicals such as lycopene, conveys significant benefits. Based on these data, we believe regular consumption of at least the daily recommended servings of fruits and vegetables would promote breast cancer prevention in an at-risk population.”

The longitudinal crossover research studied the effects of both tomato-rich and soy-rich diets in a group of 70 postmenopausal women. The women ate tomato products containing at least 25 mg of lycopene daily for 10 weeks. For a separate 10-week period, the participants consumed at least 40 g of soy protein daily. Before each test period began, the women were instructed to not eat both tomato and soy products for two weeks.

When they ate the tomato-rich diet, participants’ levels of adiponectin, a hormone involved in controlling blood sugar and fat levels, climbed 9%. The effect was slightly stronger in women who had a lower body mass index. “The findings demonstrate the importance of obesity prevention,” Dr. Llanos said. “Consuming a diet rich in tomatoes had a larger impact on hormone levels in women who maintained a healthy weight.”

The soy diet was tied to a decrease in study participants’ adiponectin levels. Researchers first hypothesized that a diet containing large amounts of soy could be part of the reason that Asian women have lower rates of breast cancer than women in the United States, but any beneficial effect may be limited to specific ethnic groups, according to Dr. Llanos.

Related Links:

Rutgers University



Print article

Channels

Drug Discovery

view channel
Image: A scanning electron microscope (SEM) image of methicillin-resistant Staphylococcus aureus bacteria (Photo courtesy of the CDC).

Drug Combination Cures MRSA Infection While Preventing Development of Resistance

Treatment with a combination comprising the well-known antibiotic cefdinir and the experimental drug TXA709 cured mice of drug-resistant staphylococcal infections while reducing the development of resistance.... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Lab Technologies

view channel
Image: A three-dimensional printer adapted for stem cell production (Photo courtesy of Nano Dimension).

Israeli Developers Demonstrate Prototype Three-Dimensional Bioprinter

Two Israeli companies have combined efforts in the development of three-dimensional printer technology for the production of stem cells. The three-dimensional print electronics developer Nano Dimension... Read more

Business

view channel

Acquisition to Boost Development of Drugs for Neurogenic Conditions

According to a recent announcement, a privately held biotechnology/drug development company is to be acquired by one of the major pharmaceutical manufacturers. The drug manufacturer Merck & Co. (Kenilworth, NJ, USA) has agreed to pay 500 million USD up front for Afferent Pharmaceuticals (San Mateo, CA, USA) and up... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.